Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Detrusor Hyperreflexia”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Large-scale testing (Phase 3)Study completedNCT02751931
What this trial is testing

Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 91
Early research (Phase 1)Study completedNCT03168828
What this trial is testing

Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord Injury

Who this might be right for
Neurogenic Detrusor Overactivity
Taris Biomedical LLC 7
Not applicableStudy completedNCT01226706
What this trial is testing

Efficacy of Botulinum Toxin Type A for the Treatment of Non-neurogenic Urinary Urge Incontinence

Who this might be right for
Urinary Urge Incontinence
Saskatchewan Health Authority - Regina Area 21
Early research (Phase 1)Study completedNCT01539707
What this trial is testing

Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Astellas Pharma Inc 14
Early research (Phase 1)Study completedNCT04478357
What this trial is testing

BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS (TOVIAZ™), MANUFACTURED AT ZWICKAU VERSUS FREIBURG

Who this might be right for
Neurogenic Detrusor Overactivity
Pfizer 18
Testing effectiveness (Phase 2)Study completedNCT01357980
What this trial is testing

Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis

Who this might be right for
Detrusor Muscle Hyperactivity
Ipsen 47
Early research (Phase 1)Study completedNCT02526979
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 9
Post-approval studies (Phase 4)Study completedNCT00224016
What this trial is testing

Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition

Who this might be right for
Detrusor Hyperreflexia
Watson Pharmaceuticals 57
Large-scale testing (Phase 3)Study completedNCT01091727
What this trial is testing

Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Sunnybrook Health Sciences Centre 57
Not applicableStudy completedNCT03388086
What this trial is testing

Efficacy of Two Onabotulinum Toxin Doses

Who this might be right for
Neurogenic BladderOveractive Detrusor
Swiss Paraplegic Research, Nottwil 56
Post-approval studies (Phase 4)Study completedNCT00629642
What this trial is testing

Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis

Who this might be right for
Multiple SclerosisNeurogenic BladderSpinal Cord Diseases
Astellas Pharma Inc 249
Post-approval studies (Phase 4)Study completedNCT02601287
What this trial is testing

A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients

Who this might be right for
Urinary IncontinenceOveractive Bladder
Allergan 168
Not applicableStudy completedNCT06059066
What this trial is testing

Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction

Who this might be right for
Neurogenic BladderLower Urinary Tract SymptomsOveractive Bladder+2 more
The Methodist Hospital Research Institute 78
Testing effectiveness (Phase 2)Study completedNCT00857896
What this trial is testing

Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Pfizer 21
Not applicableStudy completedNCT02010788
What this trial is testing

Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea

Who this might be right for
Urinary IncontinenceUrinary Bladder, Overactive
Allergan 523
Testing effectiveness (Phase 2)WithdrawnNCT00262496
What this trial is testing

Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach.

Who this might be right for
Overactive BladderUrinary Incontinence
US Department of Veterans Affairs
Not applicableLooking for participantsNCT03965299
What this trial is testing

Transcutaneous Tibial Nerve Stimulation in Acute Spinal Cord Injury

Who this might be right for
Spinal Cord Injury, Acute
University of Zurich 114
Not applicableStudy completedNCT01297660
What this trial is testing

Neuro-urological Outcome After Spinal Cord Injury

Who this might be right for
Urinary Bladder Neurogenic Dysfunction
Balgrist University Hospital 55
Not applicableWithdrawnNCT01043848
What this trial is testing

Treatment of Neurogenic Detrusor Overactivity: Early Versus Late Pudendal Nerve Stimulation in Spinal Cord Injury (SCI) Patients

Who this might be right for
Neurogenic Detrusor OveractivitySpinal Cord Injury
Ulrich Mehnert
Large-scale testing (Phase 3)Looking for participantsNCT05491525
What this trial is testing

Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

Who this might be right for
Neurogenic Detrusor Overactivity
Urovant Sciences GmbH 85
Load More Results